TearLab Corporation is on the Cruelty Free Investing animal use list as the company performs animal testing as a part of their medical research and development.
“In an animal model of ocular surface disease, tear hyperosmolarity resulted in conjunctival goblet cell death and tear film instability.“
TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. [Source: Reuters]
Company Website: https://www.tearlab.com